News > In the News

In the News


October 8th 2017

IOPtima featured in Eye World Video Reporter

Dr. Shamira Perera explaining CLASS and its advantages during this year’s ESCRS congress in Lisbon

 

View video


October 2nd 2017

IOPtima featrued in Healio Ocular Surgery Today

IOPtima Launches LIPITEAR Phospholipid Microemulsion

 

Click here to read

For more information visit: www.lipitear.com


September 28th 2017

IOPtima featrued in Eyewire Today

IOPtima Launches LIPITEAR Phospholipid Microemulsion for Ophthalmic Use

IOPtima announced the launch of LIPITEAR, a microemulsion formed by an aqueous phase and a lipidic phase that helps to restore the proper microenvironment of the ocular surface, enhances the physiological process of corneal re-epithelization following ocular surgery, and reduces the typical symptoms and signs of ocular surface disorder (OSD).

OSD encompasses different types of diseases related to damage of the surface of the cornea, including dry eye syndrome, typical symptoms after ocular surgery, and corneal erosions. OSD can severely affect eyesight and quality of life. Symptoms may include blurry vision, discomfort or pain, redness and itching, and in severe cases, blindness due to corneal scarring.

The alteration of the lipid layer results in evaporation of the aqueous layer, which in turn leads to reduced nourishing factors, alteration of epithelial cell activity and replication and hyperosmolarity that causes goblet cell death and reduction in corneal glycogen. Irregular lipid layer also causes optical aberrations clinically, resulting in a reduction of visual acuity and general quality of vision. Reduced lubricant power can lead to irritation, heavy/swollen eyelids and foreign body sensation as well.

Therefore, in the treatment of OSD, the therapeutic goal should be to support reparative processes and relieve symptoms. Whereas many treatments for OSD are mainly water-based artificial tears supplemented with variety of viscose substances, LIPITEAR offers a formula that most closely mirrors the natural tear film and can restore both the aqueous and the protective lipid layer of the tear film, according to a company news release.

Use of the LIPITEAR formula results in:

  • A restored proper microenvironment on the ocular surface
  • An enhanced, uniform physiological process of corneal re-epithelialization following ocular surgery
  • The reduction of pain/burning sensation, blurred vision, foreign body sensation, photophobia and lacrimation

This indicates a preferred usage after ocular surgery (e.g. refractive surgery, cataract surgery and corneal transplant), as well as for traumatic and spontaneous corneal erosions and dry eye syndrome.

Click here to read

For more information visit: www.lipitear.com


September 20th 2017

CLASS featured in Ophthalmology Times

Flexible glaucoma procedure serves wide variety of patients

Dr. Juan Carlos Izquierdo, MD, showing his 1 year results with our CLASS estblishing it as an effective procedure to reduce IOP while keeping better visual acuity: “It was concluded that CLASS was as effective as trabeculectomy, with fewer complications and better maintenance of visual acuity. While very effective as a stand-alone procedure, the CLASS procedure also yields excellent outcomes when combined with phacoemulsification in patients with comorbid cataract and glaucoma.”

Click here to read


September 19th 2017

CLASS featured in Cataract and Refractive Surgery Today

When is Cataract Surgery Not Enough to Manage Glaucoma?

Dr. Nir Shoham-Hazon, MD, explains how and when he selects cataract surgery alone or in combination with other procedures to control IOP in glaucoma patients. He says: “The nonpenetrating CLASS procedure has been shown to be safer and more effective than other nonpenetrating glaucoma procedures. It provides IOP control similar to that of trabeculectomy, and it can be performed by cataract and glaucoma surgeons as a standalone procedure or in combination with phacoemulsification.”

Click here to read


August 1st 2017

CLASS featured in EyeTube

CO2: A New Tool for Non Penetrating Glaucoma Surgery

Dr. Antoine Bastelica demonstrates the CLASS procedure, a novel non-penetrating treatment of CO2laser assisted sclerectomy surgery utilizing the IOPtiMate system, and presents it as an alternative to the manual non penetrating deep sclerectomy.

View video


July 12th 2017

iLid featured in EyewireToday

IOPtima announces the launch of the iLid™ CO2 laser-assisted blepharoplasty kit

View video

Click here to read


July 11th 2017

IOPtima Launches iLid™ CO2 Laser-Assisted Blepharoplasty Kit

IOPtima Ltd., today announced the launch of the iLid™ CO2 laser kit to enable oculoplastic surgeons to perform safe, effective CO2 laser-assisted blepharoplasty, a cosmetic procedure that corrects defects, deformities and disfigurations of the eyelids. Blepharoplasty can be performed manually with a surgical scalpel; the iLid™ CO2 laser kit facilitates use of a CO2 laser beam instead.

With the excision and removal and/or repositioning of excess tissues, as well as reinforcement muscle and tendon tissues, the blepharoplasty procedure is used to treat:

  • Loose or sagging skin that creates folds or disturbs the natural contour of the upper eyelids, sometimes impairing vision
  • Excess fatty deposits that appear as puffiness in the eyelids
  • Bags under the eyes
  • Drooping lower eyelids that reveal white below the iris
  • Excess skin and fine wrinkles of the lower eyelids

Using the iLid™ CO2 laser kit instead of a manual surgical scalpel, surgeons employ a CO2 laser beam with adjustable levels of penetration to incise the upper and lower eyelids and remove excess fat. The CO2 laser beam also carefully vaporizes (peels) the top layer of the skin, restoring its surface and finely smoothing the lid. Advantages iLid™ CO2 laser-assisted blepharoplasty surgery over older scalpel techniques include[1]:

  • No skin incision in the lower eyelid, eliminating any potential dragging down of the lower eyelid
  • Minimal bruising, swelling, pain and discomfort
  • Shorter recovery period
  • Less intraoperative bleeding as the laser seals blood vessels as it cuts, eliminating small subcutaneous and intramuscular hematomas
  • Dramatically reduced procedure time
  • Better cosmetic results with no visible scars

“I have been performing CO2 laser-assisted blepharoplasty for over a decade now, and I cannot imagine my practice without it. This safe procedure allows me to eliminate intraoperative bruising and swelling and provide a bloodless environment during the incision, which in turn contributes to my ability to make precise decisions in real time, thus avoiding the complications I used to experience with manual procedures,” said Dr. Paolo Bonan, Laser Surgery Researcher and Head of the Laser Cutaneous, Cosmetic and Plastic Surgery Unit, Villa Donatello, Florence, Italy. “CO2 laser-assisted blepharoplasty reduces the operation time, so we are able to treat more patients and run a more efficient operating room. And when it comes to the most important goals, our patients’ satisfaction and quality of life, we see shorter recovery time with no visible scars and better cosmetic results compared to the manual procedure.”

The iLid™ CO2 laser-assisted blepharoplasty kit is based on IOPtima’s IOPtiMate™ system for performing CLASS™ (CO2 laser-assisted sclerectomy surgery) for treatment of glaucoma. According to IOPtima CEO Ronen Castro, “Customer feedback and IOPtima’s ongoing commitment to delivering the latest product applications have driven the development of the iLid™ kit. Dual use of this technology by both glaucoma specialists and oculoplastic surgeons allows clinics to have two applications in one device and one convenient installation, broadening the scope of the clinic’s activities.”

[1] Leclère, F. M., Alcolea, J., Mordon, S., Servell, P., Kolb, F., Unglaub, F., & Trelles, M. A. (2013). Long-term outcomes of laser assisted blepharoplasty for ptosis: About 104 procedures in 52 patients. Journal of Cosmetic and Laser Therapy15(4), 193-199.


May 17th 2017

CLASS featured in EyeWorld

CO2 laser assisted sclerectomy surgery (CLASS)

Nir Shoham-Hazon, MD, discusses CO2 laser assisted sclerectomy surgery (CLASS) for the treatment of glaucoma at the 2017 ASCRS in Los Angeles.

View video


May 15th 2017

CLASS featured in Ocular Surgery News

CLASS an efficacious IOP-lowering procedure

Nir Shoham-Hazon, MD, discusses a study showing CO2 laser-assisted glaucoma surgery to be a safe and efficacious procedure in mild, moderate and severe glaucoma cases at the 2017 ASCRS in Los Angeles

View video


March 21st 2017

CLASS featured in PIE Magazine

Head of the CLASS: New Glaucoma Treatment Shines in 3-Year Results

Interview with Ehud Assia, MD on CLASS’ multi-center clinical study which was recently published in the Journal of Glaucoma of CLASS’ 3-year results

Click here to read


February 23rd 2017

CLASS featured in Glaucoma Today

Study shows significant advantages of CO2 Laser-Assisted Sclerectomy Surgery

Glaucoma Today’s coverage of the publication in Journal of Glaucoma of CLASS’ multi-center study 3-year results

Click here to read


February 20th 2017

CLASS featured in Healio, Ocular Surgery News

CO2 laser assisted sclerectomy effective, easy to learn

Ehud Assia, MD, discusses the results of CLASS’ multi-center study in light of the recent publication in Journal of Glaucoma

Click here to read


January 20th 2017

CLASS featured in The Ophthalmologists

A Long Term Look at CLASS – The 5-year trial results are in. How safe and effective is the CLASS procedure?

Noa Geffen, MD, share 5 years follow up data of CLASS’ multi-center study in the ‘Laser Quest for a Happy Medium’

Click here to read


December 12th 2016

CLASS featured in Eyewire Today

Three-year Study Shows Significant Advantages of CLASS (CO2 Laser Assisted Sclerectomy Surgery) for Patients with Glaucoma

IOPtima announced the publication of 3-year follow up data from a multicenter study

Click here to read


November 28th 2016

CLASS featured in Ocular Surgery News

Surgeon gives pearls on performing CLASS procedure to lower IOP

Juan Carlos Izquierdo, MD, discusses his experience performing the CLASS procedure and his recent clinical studies at the 2016 AAO in Chicago

View video


September 20th 2016

CLASS featured in Ocular Surgery News

Surgeon shares pearls on CLASS procedure for IOP reduction

Shamira Perera, MD, shares surgical pearls he has learned performing the IOPtima CLASS CO2 laser-assisted sclerectomy surgical procedure for the reduction of IOP at the 2016 ESCRS in Copenhagen

View video


September 12th 2016

CLASS featured in EyeWorld

CO2 Laser Assisted Sclerectomy Surgery for Glaucoma

Nir Shoham-Hazon, MD, discusses outcomes with CO2 laser assisted sclerectomy surgery for glaucoma, when combined with phacoemulsification at the 2016 ESCRS in Copenhagen

View video


August 1st 2016

CLASS featured in Ophthalmology Times

CO2 laser-assisted procedure showing long-term efficacy, safety

Michael Mimouni, MD, and Noa Geffen, MD, share 5 years follow up data of CLASS’ multi-center study as presented at the 12th European Glaucoma Society Congress.

Click here to read


June 29th 2016

CLASS featured in Oftalmologo Aldia

Entrevista Dr. Juan Carlos Izquierdo

Entrevista con el Doctor Juan Carlos Izquierdo de Perú, quien nos habla un poco acerca de un nuevo procedimiento de IOPtima, procedimiento láser CO2, en IV Congreso Internacional de Glaucoma.

View video


June 14th 2016

CLASS featured in Ocular surgery News (OSN) – Latin American

Procedimiento de CLASS: Tratamiento del glaucoma menos invasivo

Juan Carlos Izquierdo, MD, discusses results and pearls of his CLASS procedures.

Click here to read


April 12th 2016

CLASS featured in Eyetube

CLASS Procedure

Dr. Nir Shoham-Hazon demonstrates the CLASS procedure, a novel non-penetrating treatment of CO2 laser assisted sclerectomy surgery utilizing the IOPtiMate system.

View video


February 8th 2016

CLASS featured in ASCRS’ EyeWorld

CLASS Procedure for Glaucoma

Juan Carlos Izquierdo, MD, interviewed by Josh Young, MD, at the WOC about his experience with CLASS at his clinic, Oftalmosalud, in Lima, Peru.

View video


February 8th 2016

CLASS featured in International Council of Ophthalmology

CO2 Laser-Assisted Deep Sclerectomy Surgery (CLASS)- Short Term Results

Edward Wylegala, MD, presents his CLASS’ short term results at the Late Breaking News session at the WOC in Guadalajara.

View video


December 31st 2015

IOPtima Raises $7.2 million in Series B Financing

IOPtima announced today that it has secured a $7.2M investment from its existing shareholders and two Asia-based venture capital firms via a private placement

IOPtima Ltd., announced today that it has secured a $7.2M investment from its existing shareholders and two Asia-based venture capital firms via a private placement. The financing will help IOPtima to continue the global commercialization of its innovative IOPtimate® system used in the treatment of glaucoma, as well as to initiate a regulatory approval pathway process for the IOPtiMate® system with the U.S. Food and Drug Administration, commencing 2016.

IOPtima’s flagship product, IOPtiMate®, is based on CO2 laser technology that enables the performance of a unique filtration surgery to treat glaucoma without penetrating the inner part of the eyeball. The IOPtiMate® procedure (CLASS®) provides high efficacy and allows for substantial reductions in post-operative complications and use of eye drops compared with alternatives. Recent marketing efforts by IOPtima have resulted in first sales of the IOPtiMate® in various markets in Europe and Asia.

“The company’s first product is already generating revenues and the new money will help us to develop more products and promote the FDA regulatory approval in the US market. China is a very important market for us with a great potential, because we have already received a CFDA approval and began commercial operations and because our product and procedure is very suitable for Chinese eyes. It was important for me to bring onboard Chinese investors specializing in the medical field to help us penetrate the Chinese market effectively and take advantage of the opportunities that exist in it for us” said Ronen Castro, CEO of IOPtima.

“IOPtima is a company with excellent products and an experienced and professional team with clear operative plans for the coming years. The fact that the company has already received the regulatory approval in China and the positive feedback we received from local glaucoma specialists, certainly helped our decision to invest in the company. This is just the beginning for us and we certainly see great potential for the future. Our goal to assist the company as investors who specialize in the medical field to achieve its goals” said Mr. Liu Bo, Investment Director at Infinity Beijing, the leading investor in IOPtima.


December 3rd 2015

CLASS featured in OIS.TV

IOPtima Update by CEO Ronen Castro

Ronen Castro, CEO, gives an updates on IOPtima at the Ophthalmology Innovation Summit in Las Vegas.

View video


November 24th 2015

CLASS aparecido en Ocular Surgery New – Latin America

Noa Geffen, MD discute “CLASS produce resultados prometedores a largo plazo en pacientes con glaucoma”.

Haga clic aquí para leer


October 7th 2015

CLASS featured in Ophthalmology Times

Edward Wylegala, MD discuss “CO2 laser-assisted surgery yields better sclerectomy for open-angle glaucoma”.

Click here to read


September 10th 2015

CLASS featured in Ocular Surgery News (OSN)

Noa Geffen, MD reveal “CLASS yields promising long-term results in glaucoma patients”.

Click here to read


September 10th 2015

CLASS featured in Ocular Surgery News (OSN)

CEO discusses the CLASS procedure for glaucoma surgery

Ronen Castro, CEO of IOPtima Ltd, discusses why he believes CO2 laser-assisted sclerectomy surgery should be the gold standard in glaucoma surgery during the 2015 Ophthalmology Futures European Forum in Barcelona.

View video


June 29th 2015

CLASS featured in Ophthalmology Times-Europe

Svetlana Anisimova, MD describes how “Laser-assisted procedure brings ease, precision & safety to deep sclerectomy”.

Click here to downlaod


March 29th 2015

CLASS aparecido en Ocular Surgery News – Edición Latinoamericana (Español)

Gabriel Greifner, MD entrevista de “Nova técnica para o glaucoma utiliza ablação a laser de CO2 para a esclerotomia profunda”.

Haga clic aquí para descargar


February 10th 2015

CLASS featured in Cataract & Ocular Surgery News

Gabriel Greifner, MD interviewed over a “New glaucoma technique uses CO2 laser ablation for deep sclerectomy”.

Click here to download


November 30th 2014

CLASS featured in The Ophthalmology Innovation Summit (OIS)

CLASS introductory lecture – Ronen Castro

Ronen Castro, CEO, introduced the CLASS (CO2 Laser-Assisted Sclerectomy Surgery) procedure for glaucoma, which has results comparable to trabeculectomy, but is non-invasive.

View video


November 27th 2014

CLASS featured in Glaucoma Today

Alan L. Robin, MD questions “Will the Cost of Clinical Trials Quash Change in Glaucoma Treatment?”.

Click here to download


November 27th 2014

CLASS featured in Cataract & Refractive Surgery Today, Europe

Rengaraj Venkatesh, MD describes “Phacoemulisifcation Plus CO2 Laser-Assisted Sclerectomy”.

Click here to download


November 11th 2014

CLASS featured in Eyetube

Carbon Dioxide Assisted Sclerectomy Surgery (CLASS)

Rengaraj Venkatesh, MD, describes a novel idea of doing non-penetrating glaucoma surgery using carbon dioxide laser.

View video


October 19th 2014

CLASS featured in Ocular Surgery News/Healio

CLASS procedure may be safe alternative to trabeculectomy – Ronen Castro

Ronen Castro, CEO, discusses the CO2 laser laser-assisted sclerectomy surgery (CLASS) as a safer option than trabeculectomy with similar IOP reduction at the Ophthalmology Innovation Summit in Chicago.

View video

Click here to view article


October 16th 2014

CLASS featured in ASCRS Eye World

IOPtima Update by CEO Ronen Castro

Ronen Castro, CEO, gives an updates on IOPtima at the Ophthalmology Innovation Summit in Chicago.

View video


October 13th 2014

CLASS presented in EyeWorld Video Reporter

Surgeon describes glaucoma procedure using CO2 laser – Ehud Assia

Ehud Assia, MD, describes CLASS procedure to lower IOP in glaucoma during the European Society of Cataract aand Refractive Surgeons in London.

View video


September 23rd 2014

CLASS featured in Ocular Surgery News Latin America Edition (Spanish)

Mauricio Turati, MD shows “La esclerotomia asistida por laser de CO2 reduce la PIO y el uso de medicacion”.

Click here to download


September 21th 2014

CLASS featured in Advanced Ocular Care

Robert Noecker, MD and Alan Robin, MD review “A New Option in Nonpenetrating Glaucoma Surgery: Two US Perspectives”.

Click here to download


September 17th 2014

CLASS featured in Ocular Surgery News/Healio

Rengaraj Venkatesh, MD explains “Combined phaco, CLASS procedure reduces IOP in patients with open-angle glaucoma”.

Click here to download


August 24th 2014

CLASS featured in Ocular Surgery News APAO Edition

Shlomo Melamed, MD illustrates “CLASS procedure offers alternative treatment for glaucoma”.

Click here to download


August 5th 2014

CLASS featured in Ocular Surgery News EU Edition

Shlomo Melamed, MD shows “CLASS procedure offers alternative treatment for glaucoma”.

Click here to download


July 25th 2014

CLASS featured in Ocular Surgery News U.S. Edition

Shlomo Melamed, MD describes “CLASS procedure offers alternative treatment for glaucoma”.

Click here to download


June 9th 2014

CLASS featured in Ophthalmology Times US

Shlomo Melamed, MD explains “CO2 laser surgery a new option for glaucoma”.

Click here to download


June 5th 2014

CLASS featured in Ophthalmology Times EU

Ehud Assia, MD and Shlomo Melamed, MD describe “Glaucoma surgery with CLASS”.

Click here to download


June 2nd 2014

IOPtima Announces Distribution Agreement for IOPtiMate™ Systems in China

Receives purchase commitment of 100 or more systems in one of largest global markets.

IOPtima Ltd. announced today that it has signed an exclusive distribution agreement for the sale and marketing of the IOPtiMate™ system in China, one of the world’s largest glaucoma markets. As part of the agreement, IOPtima received a commitment that at least 100 systems will be purchased during the initial term of the agreement.

The IOPtiMate™ system is a state-of-the-art system that is based on CO2 laser technology that enables the performance of a unique filtration surgery to treat glaucoma without penetrating the inner part of the eye. This allows for substantial reduction in post-operative complications and use of eye drops, compared with alternative treatments.

IOPtima’s partner in China is a well-known distributor that represents leading global brands in the diagnosis and treatment of ophthalmic diseases. Leading ophthalmologists and medical centers throughout China are among their consumers. The four-year agreement includes a minimum purchase commitment, and may be extended to an additional four years should the minimum purchase obligation be met. Under the agreement, the distributor is responsible for all local marketing, advertising, and sales activity of the IOPtiMate™ system, including on-site installation, training, and support. Revenues will consist of system sales and per-procedure fees.

In March 2014, the China Food and Drug Administration, (CFDA), approved the marketing and sale of the IOPtiMate™ system, and initial sales are expected to begin following training and evaluation in key local medical centers over the next few months.

Ronen Castro, IOPtima’s chief executive officer said, “Entering into a strategic distribution agreement in China allows us to begin commercial activities in one of the world’s largest glaucoma markets and is a major step for our company. The distributor’s commitment to purchase at least 100 IOPtiMate™ systems during the initial term of the agreement reflects their full belief in our technology and its unique solution. This agreement is a significant advancement in our plan to penetrate developing markets in Asia where there is no available solution for a large population of patients.”


May 25th 2014

CLASS featured in Eurotimes

An industry brief describes CLASS as an effective method for Glaucoma treatment

Click here to view article


May 22nd 2014

CLASS featured in Eyeworld

CLASS act: Why a new CO2 laser is competing with the gold standard – by Matt Young EyeWorld Contributing Writer

Ehud Assia, MD and Shlomo Melamed, MD, share their views and experience on the use of CLASS in the recent ICGS and WOC congresses.

Click here to download


April 11th 2014

CLASS presented in Healio Ophthalmology, OSN

Surgeon describes glaucoma procedure using CO2 laser – Shlomo Melamed

Shlomo Melamed, MD, shares his experience using CO2 laser to “unroof” Schlemm’s canal to lower IOP in glaucoma during the World Ophthalmology Congress in Tokyo.

View video


March 2014

CLASS featured in the Ophthalmologist

CLASS-y Laser Treats Glaucoma – Ehud Assia

Transforming complex, invasive and risky glaucoma surgery into a safe, elegant, and precise procedure.

Click here to download


March 4th 2014

IOPtima, Ltd. Granted Regulatory Approval in China for Marketing and Sales of the IOPtimate™ System

IOPtima, Ltd. received Chinese Food and Drug Administration (CFDA) approval to market and sell the IOPtimate™ system in China, the world’s largest glaucoma market.

“Securing the CFDA approval in China is a significant milestone for the company”, said IOPtima CEO Ronen Castro. “Due to sheer size of the country’s population, the number of glaucoma patients in China is the largest of any market in the world. This represents a great business opportunity for us. Beyond the large number of general care hospitals, in China there are approximately 600 hospitals that specialize in ophthalmology, a significantly greater number than in other markets. As a result of the many advantages of the IOPtimate™ system in performing non-penetrating glaucoma surgery in a very easy and safe manner, we expect that over time, the system will capture significant market share in these specialized hospitals.”

The registration process in China was carried out by China Meheco Corporation, a company incorporated under the laws of People’s Republic of China, which is expected to perform the importation into the country. IOPtima anticipates identifying a distributor to launch sales of IOPtimate™ in China in the near future.

IOPtima plans to officially launch the IOPtimate™ system in China at the International Congress of Ophthalmology and Optometry China (COOC), being held March 27-30, 2014 in Shanghai.